FDA warning and Matthew Perry’s death darken ketamine’s glow
Published
Federal health authorities are intensifying their scrutiny of the drug ketamine for treating mental health disorders, as the mind-altering compound grows in popularity despite the lack of regulatory approval for such use. Get a curated selection of 10 of our best stories in your inbox every…
#matthewperry #fda #spravato #psychotherapists #practitioners #perry #beckleywaves #telehealth #nuelife #pitchbook